WallStreetZenWallStreetZen

NYSE: NVS
Novartis Ag Stock

$89.49-0.35 (-0.39%)
Updated Jan 27, 2023
NVS Price
$89.49
Fair Value Price
N/A
Market Cap
$193.92B
52 Week Low
$74.09
52 Week High
$94.26
P/E
9.14x
P/B
3.19x
P/S
3.15x
PEG
N/A
Dividend Yield
3.75%
Revenue
$52.26B
Earnings
$21.80B
Gross Margin
70.6%
Operating Margin
46.7%
Profit Margin
41.7%
Debt to Equity
0.95
Operating Cash Flow
$14B
Beta
0.56
Next Earnings
Feb 1, 2023
Ex-Dividend
N/A
Next Dividend
N/A

NVS Overview

Novartis AG manufactures prescription medications related to oncology, ophthalmology, neuroscience, immunology, respiratory, and cardio-metabolic medicine. Novartis AG is collaborating with Alnylam Pharmaceuticals to commercialize inclisiran. The company is also collaborating with Kura Oncology, Inc. to evaluate the combination of Tipifarnib and Alpelisib in patients with head and neck squamous cell carcinoma. Novartis AG was incorporated in 1996 and is headquartered in Basel, Switzerland.

Zen Score

Industry Average (44)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how NVS scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

NVS is forecast by analysts to be unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
NVS is good value based on its earnings relative to its share price (9.14x), compared to the US market average (23.59x)
P/E vs Market Valuation
NVS is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more NVS due diligence checks available for Premium users.

Be the first to know about important NVS news, forecast changes, insider trades & much more!

NVS News

Valuation

NVS price to earnings (PE)

For valuing profitable companies with steady earnings
Company
9.14x
Industry
30.12x
Market
23.59x
NVS is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
NVS is good value based... subscribe to Premium to read more.
P/E vs Market Valuation

NVS price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
3.19x
Industry
5.24x
NVS is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

NVS's financial health

Profit margin

Revenue
$12.8B
Net Income
$1.6B
Profit Margin
12.2%
NVS's Earnings (EBIT) of $24.41B... subscribe to Premium to read more.
Interest Coverage Financials
NVS's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$118.5B
Liabilities
$57.6B
Debt to equity
0.95
NVS's short-term assets ($36.95B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
NVS's short-term assets ($36.95B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
NVS's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
NVS's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
$4.7B
Investing
$5.2B
Financing
-$4.7B
NVS's operating cash flow ($14.01B)... subscribe to Premium to read more.
Debt Coverage Financials

NVS vs General Drug Manufacturer Stocks

TickerMarket Cap1d %P/EP/B
NVS$193.92B-0.39%9.14x3.19x
AZN$202.88B-0.70%118.07x5.77x
BMY$154.04B-0.74%23.45x4.71x
PFE$245.81B-1.04%8.25x2.65x
AMGN$135.34B-0.48%20.26x37.05x

Novartis Ag Stock FAQ

What is Novartis Ag's quote symbol?

NYSE: NVS) Novartis Ag trades on the NYSE under the ticker symbol NVS. Novartis Ag stock quotes can also be displayed as NYSE: NVS.

If you're new to stock investing, here's how to buy Novartis Ag stock.

What is the 52 week high and low for Novartis Ag (NYSE: NVS)?

(NYSE: NVS) Novartis Ag's 52-week high was $94.26, and its 52-week low was $74.09. It is currently -5.06% from its 52-week high and 20.79% from its 52-week low.

How much is Novartis Ag stock worth today?

(NYSE: NVS) Novartis Ag currently has 2,167,000,000 outstanding shares. With Novartis Ag stock trading at $89.49 per share, the total value of Novartis Ag stock (market capitalization) is $193.92B.

Novartis Ag stock was originally listed at a price of $40.69 in Dec 31, 1997. If you had invested in Novartis Ag stock at $40.69, your return over the last 25 years would have been 119.96%, for an annualized return of 3.2% (not including any dividends or dividend reinvestments).

How much is Novartis Ag's stock price per share?

(NYSE: NVS) Novartis Ag stock price per share is $89.49 today (as of Jan 27, 2023).

What is Novartis Ag's Market Cap?

(NYSE: NVS) Novartis Ag's market cap is $193.92B, as of Jan 28, 2023.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Novartis Ag's market cap is calculated by multiplying NVS's current stock price of $89.49 by NVS's total outstanding shares of 2,167,000,000.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.